Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study ; volume:21 ; number:1 ; day:26 ; month:8 ; year:2021 ; pages:1-10 ; date:12.2021
BMC infectious diseases ; 21, Heft 1 (26.8.2021), 1-10, 12.2021
- Urheber
-
Grzegorzewska, Alicja E.
Mostowska, Adrianna
Warchoł, Wojciech
Jagodziński, Paweł P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-021-06597-4
- URN
-
urn:nbn:de:101:1-2021111119394777633334
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grzegorzewska, Alicja E.
- Mostowska, Adrianna
- Warchoł, Wojciech
- Jagodziński, Paweł P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Human paraoxonase 2
Kinetics of small and middle molecule clearance during continuous hemodialysis
HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?
Serum-Paraoxonase-Polymorphismus in Japan
Spontaneous clearance of serum HCV-RNA after splenectomy in a patient with HCV-related liver cirrhosis and portal hypertension: a case report
HCV
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Human paraoxonase 2
Kinetics of small and middle molecule clearance during continuous hemodialysis
HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?
Serum-Paraoxonase-Polymorphismus in Japan
Spontaneous clearance of serum HCV-RNA after splenectomy in a patient with HCV-related liver cirrhosis and portal hypertension: a case report
HCV
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Human paraoxonase 2
Kinetics of small and middle molecule clearance during continuous hemodialysis
HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?
Serum-Paraoxonase-Polymorphismus in Japan
Spontaneous clearance of serum HCV-RNA after splenectomy in a patient with HCV-related liver cirrhosis and portal hypertension: a case report
HCV
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response